Stephanie Koller, Jonatan Kendler, Jasmine Karacs, Andrea Wolf, Caroline Kreuzinger, Isabel Von Der Decken, . . . Theresia Thalhammer. (2022). SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer. Frontiers Media S.A..
Chicago Style (17th ed.) CitationStephanie Koller, et al. SLCO4A1 Expression Is Associated with Activated Inflammatory Pathways in High-grade Serous Ovarian Cancer. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationStephanie Koller, et al. SLCO4A1 Expression Is Associated with Activated Inflammatory Pathways in High-grade Serous Ovarian Cancer. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.